Mucoangin Citron (Ambroxol Hydrochloride)

Ambroxol Hydrochloride, the active ingredient in Mucoangin Citron, is a mucolytic presented as a mucolytic formulation for oromucosal use. It helps reduce mucus viscosity and supports expectoration in patients with productive coughs due to acute or chronic bronchitis.

GNH USA supplies Mucoangin Citron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Ambroxol Hydrochloride is used as a mucolytic agent to improve clearance of respiratory secretions in several respiratory conditions. - Acute bronchitis: reduces mucus thickness and facilitates expectoration, helping relieve productive cough. - Chronic bronchitis: improves mucociliary clearance, decreasing cough frequency and sputum retention. - Cough with thick mucus: softens secretions to enable easier expectoration and improve breathing comfort.

Ambroxol Hydrochloride may be associated with several adverse reactions, ranging from mild to rare serious events.

Common Side Effects: - Taste alteration: transient metallic or bitter taste. - Nausea: mild stomach upset. - Diarrhea: loose stools. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Allergic reaction: urticaria, angioedema, or anaphylaxis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes.

When prescribing Ambroxol Hydrochloride, clinicians should consider several precautionary measures to ensure safe use. - Renal impairment: adjust use if severe kidney dysfunction is present. - Hepatic disease: monitor liver function in patients with existing liver conditions. - Asthma: observe for bronchospasm, especially in patients with a history of reactive airway disease. - Pregnancy: use only if potential benefit justifies potential risk; consult obstetric guidance. - Concomitant mucolytics: avoid simultaneous use of multiple mucolytic agents to prevent excess irritation. - Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight in the original packaging.

Ambroxol Hydrochloride can interact with other medicines, affecting its efficacy or safety profile.

Major Interactions (Avoid): - Anticholinergic agents: may reduce mucociliary clearance, diminishing therapeutic effect. - Strong CYP3A4 inhibitors: potential increase in systemic exposure, though clinical relevance is limited.

Moderate Interactions (Monitor Closely): - Other mucolytics or expectorants: additive effect may cause excessive mucus thinning. - Bronchodilators: monitor for enhanced bronchial response. - NSAIDs: watch for increased gastrointestinal irritation.